Skip to main content
. Author manuscript; available in PMC: 2024 Jan 4.
Published in final edited form as: J Drug Issues. 2022 Aug 2;53(2):296–320. doi: 10.1177/00220426221109948

Table 2.

Descriptive Statistics for Main Study Variables. State surveys (n = 42) Local surveys (n = 849).

State Survey Local Survey
n % or Mean n % or Mean
Variables (indicates % able to answer this question)
Mean number of courts in state (100%) 42 67 n/a n/a
Mean number of PSC participants (60%, 70%) 26 2,658 587 77
Mean time to PSC graduation (100% both groups)
 under 20 months n/a n/a 668 63%
 over 20 months n/a n/a 668 37%
Mean number of courts offering MAT n/a n/a 568 86%
 Court offers buprenorphine n/a n/a 428 50%
 Court offers methadone n/a n/a 306 36%
 Court offers naltrexone n/a n/a 479 56%
 Mean PSC graduation rate n/a n/a 535 41%
 Medicaid expansion state 43 72% 849 62%
Court types coordinated
 Adult drug 42 98% 849 37%
 Mental health 42 93% 849 6%
 Veteran’s treatment 42 93% 849 5%
 Family dependency 42 86% 849 7%
 DUI/DWI 42 84% 849 5%
 Coordinated multiple types of courts n/a n/a 849 40%
Sources of funding for operational costs
 Federal 41 70% n/a n/a
 State 41 91% n/a n/a
 Local 41 72% n/a n/a
 Participant fees 41 67% n/a n/a
 Other (i.e., foundation money and 501(c) (3)) incentives) 41 9% n/a n/a
Staffing of PSC
 Average size n/a n/a 644 11
 Average participants to staff ratio (64%) n/a n/a 553 8:1
Average length in position
 3 years or less n/a n/a 815 39%
 4 or more years n/a n/a 815 61%
Characteristics of PSC participants (50%, 50%)
 White 14 76% 419 79%
 Men 14 66% 446 63%
 Non-hispanic or latino 12 85% 326 91%

Note. Sample size reflects the number of available cases from the full sample of 849.